Podcast Episodes

Back to Search
EP292: Teladoc Buys Livongo: What Are the Implications for Providers, Employers, and the Market? Part 1, With Bob Matthews and Dan O'Neill, MA, MS
EP292: Teladoc Buys Livongo: What Are the Implications for Providers, Employers, and the Market? Part 1, With Bob Matthews and Dan O'Neill, MA, MS

Episode 292

This is episode 1 of a two-part show about the potential impact of the Teladoc acquisition of Livongo. To get started here, in deference to the fact …

5 years, 8 months ago

Short Long
View Episode
EP291: What Are Medicare Advantage Plans Up to Right About Now? With Betsy Seals, Cofounder of the Rebellis Group
EP291: What Are Medicare Advantage Plans Up to Right About Now? With Betsy Seals, Cofounder of the Rebellis Group

Episode 291

Medicare Advantage (MA) enrollment has nearly doubled over the past decade. It grew 37% from 2016 to 2020. Right now, MA comprises nearly 40% of the …

5 years, 8 months ago

Short Long
View Episode
Encore! EP225: Why, Right Now, It Is No Longer Optional to Suck at Patient Centricity, With Joe Selby, MD, MPH, Former Executive Director of PCORI
Encore! EP225: Why, Right Now, It Is No Longer Optional to Suck at Patient Centricity, With Joe Selby, MD, MPH, Former Executive Director of PCORI

There is a land grab going on right now, the likes of which the health care industry hasn't seen before—at least in our generation. Spoiler alert: Th…

5 years, 8 months ago

Short Long
View Episode
EP290: COVID-19—Shining a Light on the Crafty Gambits Used by Some (Not All) Hospital Billing Departments, With Doug Aldeen
EP290: COVID-19—Shining a Light on the Crafty Gambits Used by Some (Not All) Hospital Billing Departments, With Doug Aldeen

Episode 290

Here's a couple of sentences ripped from the headlines recently: It is free to be tested for COVID-19 in the US, but the cost of treatment can be sho…

5 years, 9 months ago

Short Long
View Episode
EP289: The Right Amount of Oncology Screening and Care—In a Pandemic and Not in a Pandemic, With Bishal Gyawali, MD, PhD
EP289: The Right Amount of Oncology Screening and Care—In a Pandemic and Not in a Pandemic, With Bishal Gyawali, MD, PhD

Episode 289

You may or may not know (I don't know why you would, honestly), but I speak Swedish. I mention this because there's this famous and really culturally…

5 years, 9 months ago

Short Long
View Episode
EP288: The "Big Three" PBMs Spinning Up GPOs—What? With Mike Schneider, Principal at Avalere Health
EP288: The "Big Three" PBMs Spinning Up GPOs—What? With Mike Schneider, Principal at Avalere Health

Episode 288

Disclaimer before we get started here: This show is probably a 300-level class in pharmaceutical/PBM relations. If you are tuning in for the first ti…

5 years, 9 months ago

Short Long
View Episode
EP287: The Time for Entrepreneurial Physician Leaders Is Right Now, With Dan O'Neill, MA, MS
EP287: The Time for Entrepreneurial Physician Leaders Is Right Now, With Dan O'Neill, MA, MS

Episode 287

In this health care podcast, I'm speaking with Dan O'Neill, MA, MS. Dan says that, in many ways, this is a fantastic time to be an entrepreneurial ph…

5 years, 9 months ago

Short Long
View Episode
EP286: Advice for Health Systems in the Face of Consumerism and Value-based Contracts, With John Rodis, MD, MBA
EP286: Advice for Health Systems in the Face of Consumerism and Value-based Contracts, With John Rodis, MD, MBA

Episode 286

John Rodis, MD, MBA, is an OB/GYN specializing in high-risk pregnancies. He's been a board examiner and a department chairman. He's been a COO and a …

5 years, 9 months ago

Short Long
View Episode
EP285: The Fascinating Story of Billions of Dollars Going Missing When the Back Office Pays Health Care Bills, With Dawn Cornelis, Cofounder and Director of Transparency at ClaimInformatics
EP285: The Fascinating Story of Billions of Dollars Going Missing When the Back Office Pays Health Care Bills, With Dawn Cornelis, Cofounder and Director of Transparency at ClaimInformatics

Episode 285

I'm going to summarize some points that Dr. Marty Makary made in his manifesto for why he wrote his most recent book. The Price We Pay is its name. Y…

5 years, 10 months ago

Short Long
View Episode
EP284: When Prescribers Know How Much a Drug Will Cost Patients at the Point of Prescribing, With Carm Huntress, CEO and Cofounder of RxRevu
EP284: When Prescribers Know How Much a Drug Will Cost Patients at the Point of Prescribing, With Carm Huntress, CEO and Cofounder of RxRevu

Episode 284

There is a transparency zeitgeist kicking off right about now. In June was the biggie, the one where health systems now have to divulge their contrac…

5 years, 10 months ago

Short Long
View Episode

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us